权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Dayton Clinical Oncology Program

代顿临床肿瘤学项目

基本信息

批准号：
9117475
负责人：
Howard M Gross
金额：
$ 85.5万
依托单位：
DAYTON CLINICAL ONCOLOGY PROGRAM
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-08-01 至 2019-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9117475
关键词：
Accounting Address Adult Affect Agreement Area Budgets Bylaw Cancer Control Caring Chairperson Clinical Oncology Clinical Trials Communities Community Clinical Oncology Program Comorbidity Consent Contracts Data Databases Doctor of Medicine Education Ensure Funding Gastroenterology Genomics Goals Governing Board Grant Gynecology Healthcare Systems Hospitals Human Resources Incidence Indiana Institution Kentucky Longitudinal Studies Lung Malignant Neoplasms Medical center Minority Mission Modality Modeling Nursing Research Observational Study Ohio Operative Surgical Procedures Patient-Focused Outcomes Patients Pattern Physicians Population Postdoctoral Fellow Prevention Prevention Protocols Principal Investigator Process Protocols documentation Quality of life Radiation therapy Reporting Research Research Infrastructure Research Personnel Research Project Grants Services Site Stress Underserved Population Universities Urology Woman anticancer research base cancer care cancer clinical trial cancer prevention cancer therapy care delivery community organizations community setting control trial data sharing design improved medical specialties meetings member mortality oncology oncology program programs public health relevance screening social treatment trial

项目摘要

DESCRIPTION (provided by applicant): The Dayton Clinical Oncology Program (DCOP) was incorporated in the State of Ohio in 1982 as a non-profit 501 C-3 corporation. A Consortium Agreement was established between DCOP, the Dayton Area adult hospitals, and Wright State University (WSU). A governing board was established, and corporate bylaws were developed. Currently, DCOP has an elected Board of Directors with Howard M. Gross, M.D., DCOP Principal investigator, as Chairperson of the Board, Stuart Marl, M.D., Associate Principal Investigator, as Vice Chairperson, Sidney J. Pinkus, MBA, Chief Executive Officer of DCOP, as President of the Board, and 15 other Directors representing the 12 member hospitals, WSU, and at-large community members of our service area. The Board meets semi-annually to review budget reports and program activities. Since 1982, DCOP has successfully applied for and received funding from NCl as a CCOP. We are currently seeking continued funding through the five fiscal year period ending May 31, 2019 as an N-CORP. Our current staff includes 17 Oncology Research Nurses funded by our member hospitals, and 18 office staff funded by the grant, including directors for quality, regulatory, research projects, and education, regulatory coordinator, data coordinators, research coordinators, administrative assistant, and research associate. Our current active physician co-investigators total 78, representing our 12 hospitals and various specialties including oncology, radiation therapy, urology, surgery, gynecology, pulmonary and gastroenterology. WSU has been providing personnel, payroll, and accounting services support through a sub-contracting relationship established on December 23, 2001, when the grant was transferred from former fiscal agent Kettering Medical Center to DCOP. DCOP has continued as the grantee organization since that date.

描述（由申请人提供）：代顿临床肿瘤学项目（DCOP）于1982年在俄亥俄州注册成立，是一家非营利性501 C-3公司。DCOP、代顿地区成人医院和赖特州立大学（WSU）之间达成了一项联合协议。成立了一个理事会，并制定了公司细则。目前，DCOP有一个由霍华德M.恶心医学博士DCOP首席研究员，董事会主席，Stuart Marl，医学博士，副首席研究员，副主席，西德尼J.平库斯，工商管理硕士，DCOP的首席执行官，董事会主席，和其他15名董事代表12个成员医院，WSU，并在广大社区成员我们的服务领域。董事会每半年举行一次会议，审查预算报告和方案活动。自1982年以来，DCOP成功地申请并获得了NCl作为CCOP的资助。我们目前正在寻求通过五个财政年度截至2019年5月31日作为一个N-CORP继续资助。我们目前的工作人员包括17名肿瘤学研究护士由我们的成员医院资助，18名办公室工作人员由赠款资助，包括质量，监管，研究项目和教育，监管协调员，数据协调员，研究协调员，行政助理，和研究助理我们目前活跃的医生合作研究者共有78人，代表我们的12家医院和各种专业，包括肿瘤学，放射治疗，泌尿外科，外科，妇科，肺和胃肠病学。 WSU一直通过2001年12月23日建立的分包关系提供人事、工资和会计服务支持，当时赠款从前财政代理人凯特林医疗中心转移到DCOP。从那时起，发展合作伙伴关系继续作为受赠组织。